Diffusionstensorgewichtete MRT bei der Alzheimer Krankheit: Prädiktion und Darstellung von symptomatischen und krankheitsmodifizierenden Behandlungseffekten von Galantamin (Reminyl®)
- Conditions
- Alzheimer's disease
- Registration Number
- EUCTR2005-003762-41-DE
- Lead Sponsor
- Department of Psychiatry, Ludwig-Maximilian University Munich
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Diagnose einer klinisch wahrscheinlichen Alzheimer Krankheit im leicht bis mittelgradigen Stadium
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Ferromagnetische Implantate einschließlich kardialer Schrittmacher
Andere neurologische oder psychiatrische Erkrankung als Alzheimer Krankheit
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method